Zydus Lifesciences bags FDA approval for Lacosamide Tablets in seizures

Pallavi Madhiraju- December 16, 2023 0

Zydus Lifesciences Limited, a prominent player in the pharmaceutical industry, has recently received final approval from the United States Food and Drug Administration (USFDA) to ... Read More

Granules India gets FDA approval for generic epilepsy drug Levetiracetam

Pallavi Madhiraju- June 16, 2023 0

Granules India has announced its receipt of approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam ... Read More

Lupin receives FDA approval for seizures medication Diazepam Rectal Gel

Pallavi Madhiraju- June 3, 2023 0

Lupin announced that its subsidiary Novel Laboratories has received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application for ... Read More

Zydus Lifesciences gets FDA final approval for Vigabatrin for Oral Solution

Pallavi Madhiraju- March 4, 2023 0

Zydus Lifesciences has bagged final approval for seizures drug Vigabatrin for Oral Solution USP, 500 mg from the US Food and Drug Administration (FDA). Vigabatrin ... Read More

Sun Pharmaceutical gets SEZABY FDA approval for neonatal seizures

Pallavi Madhiraju- November 18, 2022 0

Sun Pharmaceutical Industries has secured approval for SEZABY (phenobarbital sodium powder for injection) from the US Food and Drug Administration (FDA) for the treatment of ... Read More

Unichem Laboratories gets FDA approval for Dilantin generic

Pallavi Madhiraju- October 17, 2022 0

Unichem Laboratories Limited said that the US Food and Drug Administration (FDA) has approved its abbreviated new drug application (ANDA) for its Extended Phenytoin Sodium ... Read More

Zydus Lifesciences gets FDA final approval for Brivaracetam generic

Pallavi Madhiraju- October 6, 2022 0

Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has bagged final approval to market Brivaracetam Tablets USP 10 mg, 25 ... Read More

Lupin gets tentative FDA approval for Brivaracetam Tablets

pallavi123- August 16, 2021 0

Lupin Limited said that it has been granted tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) ... Read More

Zydus Cadila secures tentative approval from FDA for Brivaracetam Tablets

pallavi123- June 20, 2021 0

Cadila Healthcare (also known as Zydus Cadila) said that it has secured tentative approval from the US Food and Drug Administration (FDA) to market Brivaracetam ... Read More

Glenmark Pharmaceuticals launches Rufinamide Tablets in US

pallavi123- June 1, 2021 0

Glenmark Pharmaceuticals said that it has launched Rufinamide Tablets USP, 200 mg and 400 mg in the US, which is a therapeutic equivalent of Banzel ... Read More